Trials / Recruiting
RecruitingNCT06859801
A Multi-Center Observational Trial of Symptomatic, High-Risk Bone Metastases Treated With Percutaneous Ablation and Palliative Radiation Therapy
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (estimated)
- Sponsor
- Society of Interventional Oncology · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate real-world outcomes (e.g., pain, patient reported outcomes, skeletal related events, healthcare utilization, etc.) in patients treated with both percutaneous ablation and palliative radiation therapy (RT).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Percutaneous Ablation | Percutaneous ablation is a minimally invasive alternative therapy for metastatic bone disease and can be used for destruction of nerves mediating pain signals, tumor destruction, decompression, or inhibition of tumor growth. |
| RADIATION | Radiation Therapy | Radiation therapy (RT) is a widely accepted treatment for painful bone metastases and provides palliation of pain for patients. |
Timeline
- Start date
- 2025-10-23
- Primary completion
- 2027-07-31
- Completion
- 2027-07-31
- First posted
- 2025-03-05
- Last updated
- 2026-02-19
Locations
6 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06859801. Inclusion in this directory is not an endorsement.